当前位置: X-MOL 学术Int. Immunopharmacol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors
International Immunopharmacology ( IF 4.8 ) Pub Date : 2021-09-22 , DOI: 10.1016/j.intimp.2021.108168
Inas Elsayed 1 , Lin Li 2 , Kieran Sheahan 3 , Bruce Moran 4 , Salih Bakheit 5 , Xiaosheng Wang 2
Affiliation  

An in-depth investigation of the molecular and immunologic properties of colorectal adenoma is important for understanding the mechanisms of colorectal cancer (CRC) initiation and development through the adenoma pathway. We performed a meta-analysis of the gene expression data from seven CRC and colorectal sporadic conventional adenoma datasets. We compared the enrichment levels of immune signatures between adenoma, normal colon, and CRC, then applied immunohistochemistry to compare the CD3 + and CD8 + T cells infiltration using samples of adenoma, contiguous adenoma, and CRC. We identified differentially expressed genes (DEGs) between adenoma, normal colon, and CRC, then performed pathway, network, immune correlation, and survival analyses on the DEGs. Adenoma had lower enrichment levels of antitumor immune signatures (CD8 + T cells, NK cells, and MHC Class I) while higher levels of TGF-β and Th17 signatures. Immunohistochemistry revealed variations in CD3 + and CD8 + T cells infiltration between low-grade and high-grade adenomas and between adenoma, normal colon, and CRC. We identified two groups of genes, which we named (NACupGs and NACdownGs), with consistent expression elevation and reduction respectively across the normal, precancerous, and cancerous stages. 48% of the NACupGs had expression levels highly correlated with Treg and TGF-β immune signatures, of which 39% were inversely correlated with CRC survival. We conclude that anti-tumor immune response is reduced at the precancerous (adenoma) stage which is characterized by prominent TGF-β and Th17 activity. The alterations of molecular and immunological profiles in adenoma can provide new insights into the initiation and development of CRC.



中文翻译:

腺瘤到癌:结直肠散发性肿瘤的分子和免疫学特征

深入研究结直肠腺瘤的分子和免疫学特性对于了解结直肠癌 (CRC) 通过腺瘤途径发生和发展的机制非常重要。我们执行了一个-分析来自七个CRC和结直肠散发性常规腺瘤数据集的基因表达数据。我们比较了腺瘤、正常结肠和 CRC 之间免疫特征的富集水平,然后应用免疫组织化学来比较使用腺瘤、连续腺瘤和 CRC 样本的 CD3 + 和 CD8 + T 细胞浸润。我们确定了腺瘤、正常结肠和 CRC 之间的差异表达基因 (DEG),然后对 DEG 进行了通路、网络、免疫相关性和生存分析。腺瘤的抗肿瘤免疫特征(CD8 + T 细胞、NK 细胞和 MHC I 类)的富集水平较低,而 TGF-β 和 Th17 特征的富集水平较高。免疫组织化学揭示了低级别和高级别腺瘤之间以及腺瘤、正常结肠和 CRC 之间 CD3 + 和 CD8 + T 细胞浸润的差异。我们确定了两组基因,我们将其命名为(NACupGs 和 NACdownGs),它们在正常、癌前和癌变阶段分别具有一致的表达升高和降低。48% 的 NACupG 的表达水平与 Treg 和 TGF-β 免疫特征高度相关,其中 39% 与 CRC 存活率负相关。我们得出结论,抗肿瘤免疫反应在癌前(腺瘤)阶段降低,其特征是显着的 TGF-β 和 Th17 活性。腺瘤中分子和免疫学特征的改变可以为CRC的发生和发展提供新的见解。48% 的 NACupG 的表达水平与 Treg 和 TGF-β 免疫特征高度相关,其中 39% 与 CRC 存活率负相关。我们得出结论,抗肿瘤免疫反应在癌前(腺瘤)阶段降低,其特征是显着的 TGF-β 和 Th17 活性。腺瘤中分子和免疫学特征的改变可以为CRC的发生和发展提供新的见解。48% 的 NACupG 的表达水平与 Treg 和 TGF-β 免疫特征高度相关,其中 39% 与 CRC 存活率负相关。我们得出结论,抗肿瘤免疫反应在癌前(腺瘤)阶段降低,其特征是显着的 TGF-β 和 Th17 活性。腺瘤中分子和免疫学特征的改变可以为CRC的发生和发展提供新的见解。

更新日期:2021-09-23
down
wechat
bug